News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abbott Animal Health and Oasmia Announce Exclusive Distribution Agreement for Paccal(r) Vet, a New Chemotherapeutic Agent for Dogs



7/14/2009 8:44:21 AM

ABBOTT PARK, Ill. and UPPSALA, Sweden, July 14, 2009 (GLOBE NEWSWIRE) -- Abbott and Oasmia Pharmaceutical have announced a multi-year agreement to market one of the first cancer medications for dogs. The chemotherapeutic agent, called Paccal(r) Vet (micellar paclitaxel), represents the first generation of treatments of its kind and is currently being studied to treat Grade II and Grade III canine mast cell tumors where curative surgery cannot be performed.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES